We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+0.28%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$360B
AUM Growth
-$5.05B
Cap. Flow
-$2.61B
Cap. Flow %
-0.72%
Top 10 Hldgs %
13.81%
Holding
6,930
New
170
Increased
3,227
Reduced
2,806
Closed
155

Sector Composition

Rank Sector Weight
1 Technology 11.4%
2 Financials 10.07%
3 Consumer Discretionary 8.39%
4 Healthcare 7.69%
5 Communication Services 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QTRX icon
5301
Quanterix
QTRX
$164M
$224K ﹤0.01%
13,133
-1,567
-11% -$31.4K
XBIT icon
5302
XBiotech
XBIT
$68M
$224K ﹤0.01%
41,938
+2,473
+6% +$11.4K
APB
5303
DELISTED
Asia Pacific Fund
APB
$223K ﹤0.01%
15,080
+254
+2% +$3.73K
CVR icon
5304
Chicago Rivet & Machine Co
CVR
$10M
$222K ﹤0.01%
7,247
+180
+3% +$5.7K
AKTS
5305
DELISTED
Akoustis Technologies Inc
AKTS
$222K ﹤0.01%
38,032
+7,211
+23% +$45.1K
MVIS icon
5306
Microvision
MVIS
$6.21M
$221K ﹤0.01%
195,142
-62
-0% -$78
ORMP icon
5307
Oramed Pharmaceuticals
ORMP
$167M
$220K ﹤0.01%
33,887
-2,107
-6% -$16.3K
FMK
5308
DELISTED
First Trust Mega Cap AlphaDEX Fund
FMK
$220K ﹤0.01%
6,603
+2,378
+56% +$82.6K
WBIC
5309
DELISTED
WBI BullBear Yield 2000 ETF
WBIC
$219K ﹤0.01%
9,980
+2,854
+40% +$63.7K
FTD
5310
DELISTED
FTD Companies, Inc. Common Stock
FTD
$219K ﹤0.01%
60,071
-100,416
-63% -$603K
NMTR
5311
DELISTED
9 Meters Biopharma
NMTR
$218K ﹤0.01%
+397
New +$77.3K
NBRV
5312
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$218K ﹤0.01%
174
+119
+216% +$176K
PCF
5313
High Income Securities Fund
PCF
$98.8M
$217K ﹤0.01%
24,007
-21,840
-48% -$198K
CDTX
5314
DELISTED
Cidara Therapeutics
CDTX
$216K ﹤0.01%
2,705
+1,734
+179% +$237K
CMU
5315
DELISTED
MFS High Yield Municipal Trust
CMU
$216K ﹤0.01%
48,681
+27,196
+127% +$122K
ARCT icon
5316
Arcturus Therapeutics
ARCT
$164M
$214K ﹤0.01%
38,862
+4,736
+14% +$32.7K
IMOS
5317
ChipMOS TECHNOLOGIES
IMOS
$1.65B
$213K ﹤0.01%
11,409
-2,966
-21% -$60.6K
IRIX icon
5318
IRIDEX
IRIX
$14.3M
$213K ﹤0.01%
37,249
-300
-0.8% -$2.08K
KF
5319
Korea Fund
KF
$231M
$213K ﹤0.01%
5,216
+302
+6% +$12.7K
PYN
5320
DELISTED
PIMCO New York Municipal Income Fund III
PYN
$213K ﹤0.01%
24,355
-9,173
-27% -$84.5K
EMJ
5321
DELISTED
Eaton Vance New Jersey Municipal Bond Fund
EMJ
$213K ﹤0.01%
18,194
+2,222
+14% +$26.6K
CVON
5322
DELISTED
ConvergeOne Holdings, Inc. Class A Common Stock
CVON
$212K ﹤0.01%
22,961
+22,761
+11,381% +$212K
NGVC icon
5323
Vitamin Cottage Natural Grocers
NGVC
$739M
$211K ﹤0.01%
29,597
+4,243
+17% +$32.5K
CYAD
5324
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
$211K ﹤0.01%
6,135
GALT icon
5325
Galectin Therapeutics
GALT
$196M
$210K ﹤0.01%
44,260
+28,092
+174% +$131K

Similar funds

Morgan Stanley's Q1 2018 Portfolio in Review

As of Q1 2018, Morgan Stanley held 6,930 positions worth $360B, down 1.4% from $365B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q1 2018: portfolio turnover was 4.7%. Morgan Stanley opened 170 new positions and exited 155, leaving the 6,930-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Morgan Stanley's largest Q1 2018 buy was Nutrien: 1,554,481 shares worth $73.5M.
  • Morgan Stanley added most to iShares Russell 2000 ETF in Q1 2018, an estimated $1.27B increase.
  • Morgan Stanley's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.33B.
  • Morgan Stanley fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $86M.
  • Morgan Stanley's ten largest holdings make up 14% of its $360B portfolio in Q1 2018.
  • Morgan Stanley opened 170 new positions and closed 155 in Q1 2018.
  • Morgan Stanley's portfolio value fell 1.4% quarter-over-quarter to $360B.

Based on Morgan Stanley's 13F filing for Q1 2018, filed 14 May 2018.